1. A single center evaluation of cost savings related to treatment‐free remission in chronic myeloid leukemia patients: the prerequisites of a pharmaco‐economy larger study. (10th February 2020) Authors: Etienne, Gabriel; Dulucq, Stéphanie; Faberes, Carole; Bijou, Fontanet; Schmitt, Anna; Klein, Emilie; Fort, Marie‐Pierre; Durrieu, Françoise; Toulza, Emilie; Mahon, François‐Xavier Journal: British journal of haematology Issue: Volume 189:Number 3(2020) Page Start: e97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Absence of JAK2V617F Mutated Endothelial Colony-Forming Cells in Patients With JAK2V617F Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis. Issue 3 (5th June 2020) Authors: Guy, Alexandre; Danaee, Anicee; Paschalaki, Koralia; Boureau, Lisa; Rivière, Etienne; Etienne, Gabriel; Mansier, Olivier; Laffan, Michael; Sekhar, Mallika; James, Chloe Journal: HemaSphere Issue: Volume 4:Issue 3(2020) Page Start: e364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CML patients show sperm alterations at diagnosis that are not improved with imatinib treatment. (September 2016) Authors: Nicolini, Franck-Emmanuel; Alcazer, Vincent; Huguet, Françoise; Cony-Makhoul, Pascale; Heiblig, Mael; Fort, Marie-Pierre; Morisset, Stéphane; Guerci-Bresler, Agnès; Soula, Volcy; Sobh, Mohamad; d'Estaing, Sandrine Giscard; Daudin, Myriam; Etienne, Gabriel Journal: Leukemia research Issue: Volume 48(2016:Sep.) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CML patients show sperm alterations at diagnosis that are not improved with imatinib treatment. (September 2016) Authors: Nicolini, Franck-Emmanuel; Alcazer, Vincent; Huguet, Françoise; Cony-Makhoul, Pascale; Heiblig, Mael; Fort, Marie-Pierre; Morisset, Stéphane; Guerci-Bresler, Agnès; Soula, Volcy; Sobh, Mohamad; d'Estaing, Sandrine Giscard; Daudin, Myriam; Etienne, Gabriel Journal: Leukemia research Issue: Volume 48(2016:Sep.) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients. (30th June 2021) Authors: Rousselot, Philippe; Mollica, Luigina; Guilhot, Joëlle; Guerci, Agnès; Nicolini, Franck E.; Etienne, Gabriel; Legros, Laurence; Charbonnier, Aude; Coiteux, Valérie; Dartigeas, Caroline; Escoffre‐Barbe, Martine; Roy, Lydia; Cony-Makhoul, Pascale; Dubruille, Viviane; Gardembas, Martine; Huguet, Fra... Journal: British journal of haematology Issue: Volume 194:Number 2(2021) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA‐PegIFN study). (10th October 2022) Authors: Roy, Lydia; Chomel, Jean‐Claude; Guilhot, Joëlle; Guerci‐Bresler, Agnès; Escoffre‐Barbe, Martine; Giraudier, Stéphane; Charbonnier, Aude; Dubruille, Viviane; Huguet, Françoise; Johnson‐Ansah, Hyacinthe; Lenain, Pascal; Ame, Shanti; Etienne, Gabriel; Nicolini, Franck E.; Rea, Delphine; Cony‐Makhou... Journal: British journal of haematology Issue: Volume 200:Number 2(2023) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dasatinib-Loaded Erythrocytes Trigger Apoptosis in Untreated Chronic Myelogenous Leukemic Cells: A Cellular Reservoir Participating in Dasatinib Efficiency. Issue 3 (June 2018) Authors: Airiau, Kelly; Turcq, Béatrice; Bouchet, Stéphane; Laharanne, Elodie; Vial, Jean-Philippe; Etienne, Gabriel; Mahon, François-Xavier; Belloc, Francis Journal: HemaSphere Issue: Volume 2:Issue 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group. Issue 14 (3rd May 2018) Authors: Rea, Delphine; Ame, Shanti; Berger, Marc; Cayuela, Jean‐Michel; Charbonnier, Aude; Coiteux, Valérie; Cony‐Makhoul, Pascale; Dubruille, Viviane; Dulucq, Stéphanie; Etienne, Gabriel; Legros, Laurence; Nicolini, Franck; Roche‐Lestienne, Catherine; Escoffre‐Barbe, Martine; Gardembas, Martine; Guerci‐... Journal: Cancer Issue: Volume 124:Issue 14(2018) Page Start: 2956 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+CD15− cells in early chronic‐phase chronic myeloid leukemia. Issue 6 (27th April 2018) Authors: Maupetit‐Mehouas, Stéphanie; Court, Franck; Bourgne, Céline; Guerci‐Bresler, Agnès; Cony‐Makhoul, Pascale; Johnson, Hyacinthe; Etienne, Gabriel; Rousselot, Philippe; Guyotat, Denis; Janel, Alexandre; Hermet, Eric; Saugues, Sandrine; Berger, Juliette; Arnaud, Philippe; Berger, Marc G. Journal: Molecular oncology Issue: Volume 12:Issue 6(2018) Page Start: 814 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. ELN 2013 response status criteria: Relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?. Issue 1 (25th October 2014) Authors: Etienne, Gabriel; Dulucq, Stéphanie; Lascaux, Axelle; Schmitt, Anna; Bidet, Audrey; Fort, Marie‐Pierre; Lippert, Eric; Bureau, Caroline; Adiko, Didier; Hayette, Sandrine; Reiffers, Josy; Nicolini, Franck‐Emmanuel; Mahon, François‐Xavier Journal: American journal of hematology Issue: Volume 90:Issue 1(2015:Jan.) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗